Use of Exogenous Hormones and Risk of Papillary Thyroid Cancer (Washington, United States)

被引:0
|
作者
Mary Anne Rossing
Lynda F. Voigt
Kristine G. Wicklund
Michelle Williams
Janet R. Daling
机构
[1] University of Washington,Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Department of Epidemiology, School of Public Health and Community Medicine
来源
Cancer Causes & Control | 1998年 / 9卷
关键词
Estrogen; hormone replacement therapy; oral contraceptives; thyroid cancer; women; United States;
D O I
暂无
中图分类号
学科分类号
摘要
Objectives: Greater incidence of thyroid cancer in women than men, particularly evident during the reproductive years, has led to the suggestion that female hormones may increase risk of this disease. We conducted a population-based case-control study in women aged 18 to 64 years in three counties of western Washington State (United States) to assess the relation of use of exogenous hormones, including oral contraceptives (OC) and hormone replacement therapy (HRT), to risk of papillary thyroid cancer.
引用
收藏
页码:341 / 349
页数:8
相关论文
共 50 条
  • [1] Use of exogenous hormones and risk of papillary thyroid cancer (Washington, United States)
    Rossing, MA
    Voigt, LF
    Wicklund, KG
    Williams, M
    Daling, JR
    CANCER CAUSES & CONTROL, 1998, 9 (03) : 341 - 349
  • [2] Recreational physical activity and risk of papillary thyroid cancer (United States)
    Mary Anne Rossing
    Rachel Remler
    Lynda F. Voigt
    Kristine G. Wicklund
    Janet R. Daling
    Cancer Causes & Control, 2001, 12 : 881 - 885
  • [3] Recreational physical activity and risk of papillary thyroid cancer (United States)
    Rossing, MA
    Remler, R
    Voigt, LF
    Wicklund, KG
    Daling, JR
    CANCER CAUSES & CONTROL, 2001, 12 (10) : 881 - 885
  • [4] Utilization of total thyroidectomy for papillary thyroid cancer in the United States
    Bilimoria, Karl Y.
    Bentrem, David J.
    Linn, John G.
    Freel, Andrew
    Yeh, Jen Jen
    Stewart, Andrew K.
    Winchester, David P.
    Ko, Clifford Y.
    Talamonti, Mark S.
    Sturgeon, Cord
    SURGERY, 2007, 142 (06) : 906 - 913
  • [5] Evolving variation in the extent of surgery for low-risk papillary thyroid cancer in the United States
    Montgomery, Kelsey B.
    Fazendin, Jessica M.
    Broman, Kristy K.
    SURGERY, 2023, 174 (04) : 828 - 835
  • [6] Risk of endometrial cancer following cessation of menopausal hormone use (Washington, United States)
    Green, PK
    Weiss, NS
    McKnight, B
    Voigt, LF
    Beresford, SAA
    CANCER CAUSES & CONTROL, 1996, 7 (06) : 575 - 580
  • [7] Incomplete pregnancies and risk of ovarian cancer (Washington, United States)
    Chen, MT
    Cook, LS
    Daling, JR
    Weiss, NS
    CANCER CAUSES & CONTROL, 1996, 7 (04) : 415 - 420
  • [8] Risk of second primary papillary thyroid cancer among adult cancer survivors in the United States, 2000-2015
    Schonfeld, Sara J.
    Morton, Lindsay M.
    de Gonzalez, Amy Berrington
    Curtis, Rochelle E.
    Kitahara, Cari M.
    CANCER EPIDEMIOLOGY, 2020, 64
  • [9] Modeling Thyroid Cancer Epidemiology in the United States Using Papillary Thyroid Carcinoma Microsimulation Model
    Alagoz, Oguzhan
    Zhang, Yichi
    Arroyo, Natalia
    Fernandes-Taylor, Sara
    Yang, Dou-Yan
    Krebsbach, Craig
    Venkatesh, Manasa
    Hsiao, Vivian
    Davies, Louise
    Francis, David O.
    VALUE IN HEALTH, 2024, 27 (03) : 367 - 375
  • [10] Thyroid-Stimulating Hormone, Thyroid Hormones, and Risk of Papillary Thyroid Cancer: A Nested Case-Control Study
    Huang, Huang
    Rusiecki, Jennifer
    Zhao, Nan
    Chen, Yingtai
    Ma, Shuangge
    Yu, Herbert
    Ward, Mary H.
    Udelsman, Robert
    Zhang, Yawei
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2017, 26 (08) : 1209 - 1218